| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |